Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Franck

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|February 22, 2003
The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosisLars Erdtmann, Nathalie Franck, Hervé Lerat, et al.
Dermatology (Basel, Switzerland)|October 10, 2015
Sarcoidosis in Patients Treated with Vemurafenib for Metastatic Melanoma: A Paradoxical Autoimmune ActivationCoralie Lheure, Nora Kramkimel, Nathalie Franck, et al.
Dermatology (Basel, Switzerland)|May 27, 2008
Two cases of cellulitis in the course of African tick bite fever: a fortuitous association?Sophie Bouvresse, Pascal Del Giudice, Nathalie Franck, et al.
The Oncologist|July 4, 2012
Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysisPascaline Boudou-Rouquette, Stanislas Ropert, Olivier Mir, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 9, 2020
Simultaneous quantification of dabrafenib, hydroxy-dabrafenib and trametinib in human plasma by liquid chromatography-tandem mass spectrometryDavid Balakirouchenane, Nihel Khoudour, Sarah Guégan, et al.
Archives of Dermatology|January 19, 2011
Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapySimon Jacobelli, Helene Laude, Agnes Carlotti, et al.
HIV Clinical Trials|May 29, 2002
Prevalence of HIV co-receptor polymorphisms in HIV-infected patients and uninfected volunteers in LuxembourgFrançois Roman, Nathalie Franck, Catherine Burgy, et al.
Archives of Dermatology|October 19, 2005
Evaluation of Coleman lipostructure for treatment of facial lipoatrophy in patients with human immunodeficiency virus and parameters associated with the efficiency of this techniqueMarielle Burnouf, Marc Buffet, Michaël Schwarzinger, et al.
JAMA Dermatology|November 30, 2022
Acneiform Eruption Following Elexacaftor-Tezacaftor-Ivacaftor Treatment in Patients With Cystic FibrosisLéa Okroglic, Pierre Sohier, Clémence Martin, et al.
Medicine|May 15, 2009
Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patientsMona Ben M'rad, Stéphanie Leclerc-Mercier, Philippe Blanche, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|February 22, 2003
The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosisLars Erdtmann, Nathalie Franck, Hervé Lerat, et al.
Dermatology (Basel, Switzerland)|October 10, 2015
Sarcoidosis in Patients Treated with Vemurafenib for Metastatic Melanoma: A Paradoxical Autoimmune ActivationCoralie Lheure, Nora Kramkimel, Nathalie Franck, et al.
Dermatology (Basel, Switzerland)|May 27, 2008
Two cases of cellulitis in the course of African tick bite fever: a fortuitous association?Sophie Bouvresse, Pascal Del Giudice, Nathalie Franck, et al.
The Oncologist|July 4, 2012
Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysisPascaline Boudou-Rouquette, Stanislas Ropert, Olivier Mir, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 9, 2020
Simultaneous quantification of dabrafenib, hydroxy-dabrafenib and trametinib in human plasma by liquid chromatography-tandem mass spectrometryDavid Balakirouchenane, Nihel Khoudour, Sarah Guégan, et al.
Archives of Dermatology|January 19, 2011
Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapySimon Jacobelli, Helene Laude, Agnes Carlotti, et al.
HIV Clinical Trials|May 29, 2002
Prevalence of HIV co-receptor polymorphisms in HIV-infected patients and uninfected volunteers in LuxembourgFrançois Roman, Nathalie Franck, Catherine Burgy, et al.
Archives of Dermatology|October 19, 2005
Evaluation of Coleman lipostructure for treatment of facial lipoatrophy in patients with human immunodeficiency virus and parameters associated with the efficiency of this techniqueMarielle Burnouf, Marc Buffet, Michaël Schwarzinger, et al.
JAMA Dermatology|November 30, 2022
Acneiform Eruption Following Elexacaftor-Tezacaftor-Ivacaftor Treatment in Patients With Cystic FibrosisLéa Okroglic, Pierre Sohier, Clémence Martin, et al.
Medicine|May 15, 2009
Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patientsMona Ben M'rad, Stéphanie Leclerc-Mercier, Philippe Blanche, et al.
Pageof 4